COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody?

被引：0
|
作者：
Autore, Francesco [1 ]
Visentin, Andrea [2 ]
Deodato, Marina [3 ]
Vitale, Candida [4 ]
Galli, Eugenio [1 ]
Fresa, Alberto [1 ]
Fazzi, Rita [5 ]
Sanna, Alessandro [6 ]
Olivieri, Jacopo [7 ]
Scortechini, Ilaria [8 ]
Principe, Maria Ilaria Del [9 ]
Sportoletti, Paolo [1 ,10 ,11 ]
Innocenti, Idanna [1 ]
Coscia, Marta [4 ]
Tedeschi, Alessandra [3 ]
Trentin, Livio [2 ]
Candoni, Anna [12 ]
Busca, Alessandro [4 ]
Pagano, Livio [1 ,2 ,13 ]
Laurenti, Luca [1 ,13 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Lab & Infettivolog, Rome, Italy
[2] Univ Padua, Dept Med, Hematol Unit, Padua, Italy
[3] ASST Grande Osped Metropolitano Niguarda, Div Hematol, Milan, Italy
[4] AOU Citta Salute Sci Torino, Div Hematol, Turin, Italy
[5] Azienda Osped Univ Pisana, UO Ematol, Pisa, Italy
[6] Azienda Osped Univ Careggi, Dept Oncol, Hematol Unit, Florence, Italy
[7] Azienda Sanit Univ Friuli Cent, Clin Ematol Udine, Udine, Italy
[8] Azienda osped Univ Marche, Clin Ematol, Ancona, Italy
[9] Univ Roma Tor Vergata, Dipartimento Biomed Prevenz, Rome, Italy
[10] Univ Perugia, Inst Hematol, Dept Med & Surg, AO Santa Maria della Misericordia Perugia, Perugia, Italy
[11] Univ Perugia, Ctr Hemato Oncol Res CREO, AO Santa Maria della Misericordia Perugia, Perugia, Italy
[12] Univ Modena & Reggio Emilia, Dept Med & Surg Sci, Sect Haematol, Modena, Italy
[13] Univ Cattolica Sacro Cuore, Dipartimento Diagnost Immagini Radioterapia Oncolo, Dipartimento Diagnostica Immagini, Rome, Italy
来源：
BLOOD ADVANCES | 2025年 / 9卷 / 01期
关键词：
D O I：
10.1182/bloodadvances.2024013792
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：162 / 165
页数：4
相关论文
共 50 条
  • [1] Impact of COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: a possible role of the association to anti-CD20 antibody? A multicentre SEIFEM study
    Autore, Francesco
    Visentin, Andrea
    Deodato, Marina
    Vitale, Candida
    Galli, Eugenio
    Fresa, Alberto
    Fazzi, Rita
    Sanna, Alessandro
    Olivieri, Jacopo
    Scortechini, Ilaria
    del Principe, Maria Ilaria
    Sportoletti, Paolo
    Schiattone, Luana
    Maschio, Nilla
    Facchinelli, Davide
    Coscia, Marta
    Tedeschi, Alessandra
    Trentin, Livio
    Innocenti, Idanna
    Candoni, Anna
    Busca, Alessandro
    Pagano, Livio
    Laurenti, Luca
    LEUKEMIA & LYMPHOMA, 2023, 64 : S27 - S28
  • [2] Impact of COVID-19 in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax: A Possible Role of the Association to Anti-CD20 Antibody? a Multicentre Seifem Study
    Autore, Francesco
    Visentin, Andrea
    Deodato, Marina
    Vitale, Candida
    Galli, Eugenio
    Fresa, Alberto
    Fazzi, Rita
    Sanna, Alessandro
    Olivieri, Jacopo
    Scortechini, Ilaria
    Del Principe, Maria Ilaria
    Sportoletti, Paolo
    Schiattone, Luana
    Maschio, Nilla
    Facchinelli, Davide
    Coscia, Marta
    Tedeschi, Alessandra
    Trentin, Livio
    Innocenti, Idanna
    Candoni, Anna
    Busca, Alessandro
    Pagano, Livio
    Laurenti, Luca
    BLOOD, 2023, 142
  • [3] Omission of Anti-CD20 Antibody in Chronic Lymphocytic Leukemia during COVID-19 Pandemic: Twelve Month Course of Venetoclax Is a Safe and Effective Alternative Regimen
    Shahab, Aarib M.
    Yunus, Saadia
    BLOOD, 2023, 142
  • [4] Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia
    Chuda, Ravindra R.
    Vishnu, Prakash
    Aboulafia, David
    CURRENT DRUG THERAPY, 2012, 7 (04) : 281 - 289
  • [5] Treatment of chronic lymphocytic leukemia (CLL)with the anti-CD20 antibody rituximab.
    Emmerich, B
    Huhn, D
    Peschel, C
    Wilhelm, M
    von Schilling, C
    Bentz, M
    Hallek, M
    Knauf, B
    Kuse, R
    Ho, AD
    BLOOD, 1999, 94 (10) : 309B - 309B
  • [6] Risk factors for hypogammaglobulinemia in chronic lymphocytic leukemia patients treated with anti-CD20 monoclonal antibody-based therapies
    Caitlin M. McNulty
    Emasenyie A. Isikwei
    Pragya Shrestha
    Melissa R. Snyder
    Brian F. Kabat
    Kari G. Rabe
    Susan L. Slager
    Sameer A. Parikh
    Avni Y. Joshi
    Journal of Hematopathology, 2020, 13 : 221 - 229
  • [7] Risk factors for hypogammaglobulinemia in chronic lymphocytic leukemia patients treated with anti-CD20 monoclonal antibody-based therapies
    McNulty, Caitlin M.
    Isikwei, Emasenyie A.
    Shrestha, Pragya
    Snyder, Melissa R.
    Kabat, Brian F.
    Rabe, Kari G.
    Slager, Susan L.
    Parikh, Sameer A.
    Joshi, Avni Y.
    JOURNAL OF HEMATOPATHOLOGY, 2020, 13 (04) : 221 - 229
  • [8] Impact of Anti-CD20 Antibodies on the Incidence of Secondary Cancers in Patients Treated for Chronic Lymphocytic Leukemia
    Guidez, Stephanie
    Demarquette, Helene
    Nudel, Morgane
    Le Grand, Charline
    Boyle, Eileen
    Herbaux, Charles
    Facon, Thierry
    Cazin, Bruno
    Morschhauser, Franck
    BLOOD, 2015, 126 (23)
  • [9] IMPACT OF ANTI-CD20 ANTIBODIES ON THE INCIDENCE OF SECONDARY CANCERS IN PATIENTS TREATED FOR CHRONIC LYMPHOCYTIC LEUKEMIA
    Guidez, S.
    Demarquette, H.
    Nudel, M.
    Le Grand, C.
    Herbaux, C.
    Facon, T.
    Cazin, B.
    Morschhauser, F.
    HAEMATOLOGICA, 2016, 101 : 443 - 444
  • [10] Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia
    Jain, Preetesh
    O'Brien, Susan
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (02) : 169 - 182
12345